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Abstract
Improving surgical interventions is key to improving outcomes. Ensuring the safe 
and transparent translation of such improvements is essential. Evaluation and gov-
ernance initiatives, including the IDEAL framework and the Macquarie Surgical 
Innovation Identification Tool have begun to address this. Yet without a definition 
of innovation that allows non-surgeons to identify when it is occurring, these initia-
tives are of limited value. A definition seems elusive, so we undertook a conceptual 
study of surgical innovation. This indicated common conceptual areas in discussions 
of (surgical) innovation, that we categorised alliteratively under the themes of “pur-
pose” (about drivers of innovation), “place” (about contexts of innovation), “pro-
cess” (about differentiating innovation), “product” (about tangible and intangible 
results of innovation) and “person” (about personal factors and viewpoint). These 
conceptual areas are used in varying—sometimes contradictory—ways in different 
discussions. Highlighting these conceptual areas of surgical innovation may be use-
ful in clarifying what should be reported in registries of innovation. However our 
wider conclusion was that the term “innovation” carries too much conceptual bag-
gage to inform normative inquiry about surgical practice. Instead, we propose elimi-
nation of the term “innovation” from serious discourse aimed at evaluation and reg-
ulation of surgery. In our view researchers, philosophers and policy-makers should 
consider what it is about surgical activity that needs attention and develop robust 
definitions to identify these areas: for our own focus on transparency and safety, this 
means finding criteria that can objectively identify certain risk profiles during the 
development of surgery.
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Introduction
Innovation in surgery is not always a good thing. Surgical innovation (SI) can pro-
duce harms as well as benefits. There is, therefore, a moral imperative to ensure 
that SI brings optimal benefit with minimal harm. There is widespread agreement 
that mechanisms providing greater oversight of SI should be developed [36]. This 
implies that innovation requires appropriate evaluation and that evaluation requires 
appropriate governance. Evaluation of innovation needs to be properly designed, 
conducted and reported to produce reliable high-quality evidence. “Governance” 
can take various forms, including legal regulation or monitoring arrangements. 
These aim at ensuring that innovation appropriately balances benefits and harms, 
to which patient information and consent for receiving an innovative (rather than a 
tried and tested) treatment can be calibrated. Although they are separate, evaluation 
and governance have been linked through guidance, notably the IDEAL framework, 
which sets down ways of evaluating innovation and specifies the types of studies 
required at different points in the innovation process for evaluating the innovation in 
question [26]. Yet, evaluation and governance arrangements, whatever form(s) these 
might take, first require us to grasp what counts as “surgical innovation”. Existing 
definitions of SI are often ad hoc, vary widely, rarely specify how their elements 
might be operationalised, and fail to make explicit their underlying assumptions. In 
this article, we survey and problematise existing notions of SI, ultimately conclud-
ing that it is advisable to do away with the term in this context, replacing it with 
language that better specifies our aims.
Divergent accounts of what SI is (Table 1) invite rigorous conceptualisation of 
SI.1 Importantly, we distinguish conceptualisation from definition. Briefly, a defini-
tion depends on the normative presuppositions of the defining party and the pur-
poses for which they aim to use the definition, whereas a conceptualisation attempts 
to map out underpinnings that (largely) transcend specific aims or agendas. Con-
cepts may thus encompass numerous possible definitions, and conceptualisation 
may produce greater insights into the possibilities and commitments that use of that 
concept entails than would a simple definition.
The research documented here takes place within a larger project that seeks to 
improve the safe translation of SI to everyday practice.2 The project is undertaking 
a number of discrete studies aimed at understanding and developing evaluation and 
governance of SI. To aid these studies we sought to develop a working definition of 
SI. We reasoned that a conceptualisation would clarify the conceptual areas that a 
definition might need to consider according its specific aim, and thus could be valu-
able for others with different aims. We therefore undertook a Critical Interpretive 
1 As we will discuss shortly, our work builds on significant work has already been performed on this 
topic by a team from Macquarie University led by Professor Wendy Rogers see: [30].
2 The project is the “Surgical Innovation” strand of the NIHR Bristol Biomedical Research Centre. See: 
https ://www.brist olbrc .nihr.ac.uk/our-resea rch/surgi cal-innov ation /
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Synthesis [18] to see what this revealed about the concept.3 Our synthesis of schol-
arly discussions of innovation revealed five ‘conceptual areas’ of SI. We term these 
“purpose”, “place”, “process”, “product” and “person”. In line with our initial 
aim, our research presents these conceptual areas here as a conceptual toolkit, giv-
ing examples of the ways in which they might be used (by ourselves and others) to 
define SI (in accordance with particular aims). However, we believe our main find-
ing, and that which our analysis shows most clearly, is that the concept of innovation 
is cluttered with elements that may be unhelpful and obfuscating when attempting 
to define innovation for governance purposes. We therefore suggest that an elimi-
nativist approach—where the term SI is avoided in the evaluation and governance 
of surgery in favour of more precise and definite terms—be taken in the bioethical-
surgical discourse.
Background
SI has the potential both to benefit and to harm health and wellbeing. Historically, 
innovations like anti-sepsis and anaesthesia have transformed surgery from an 
intervention that killed more often than cured, to a speciality that has dramatically 
improved health [22]. Innovations within heart surgery expanded the borders of 
survivable disease [12]. Others, like endoscopy, have increased wellbeing and low-
ered the risks and costs of surgery by removing the need for large incisions, which 
improves cosmesis and reduces recovery times [37]. Contemporary innovations in 
technique, like natural orifice surgery, may build on these developments [54], while 
3 A conceptualisation ideally requires engagement with both practice and theory. To the extent that our 
study incorporated qualitative explorations of practitioners views, we were attentive to this, but we would 
be the first to acknowledge the dearth of the literature in this area (for example, we know of only a single 
survey of patients views). Thus we are currently engaged with further qualitative exploration of both 
practitioner and patient views and experiences.
Table 1  Examples of current definitions of surgical innovation
Definition Source
“A novel procedure, a significant modification of a standard technique, a new application of or 
new indication for an established technique, or an alternative combination of an established 
technique with another therapeutic modality that was developed and tested for the first time”
[64]:793
“A new or modified surgical procedure that differs from currently accepted local practice, the 
outcomes of which have not been described, and which may entail risk to the patient”
[15]
“Departures from standard surgical practices that are both nonvalidated and major” [52]: 607
Anything that sits in the transition zone between practice variations and experimental research [73]
“A dynamic and continuous process involving the introduction of a new technology or tech-
nique that initiates a change in clinical practice”
[29]:205
“A procedure that includes at least one of the following: (i) a different risk profile from stand-
ard practice, (ii) the need for new training, (iii) the use of a different anatomical approach, 
(iv) the potential for increased cost and (v) outcomes that have not yet been described”
[39]:89
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devices used for robotic surgery potentially raise the aptitude of surgeons undertak-
ing minimal access techniques to elite levels [14].
Despite such positive developments, however, many innovations fail to deliver 
on their apparent promise. Chymopapain chemonucleolysis [79], jejuno-ileal bypass 
[54], and power morcellation of uterine fibroids [21] are among many widely 
adopted SIs abandoned because of their deleterious effects. Contemporary innova-
tions, such as vaginal mesh in gynaecology, may yet join this list [27].
Failed innovations can damage the lives of patients, their loved-ones, and the rep-
utation of surgery and surgeons. We suggest improving the safe translation of inno-
vations is an ethical and a pragmatic imperative. One way to do this is to improve 
standards of reporting in surgery by identifying innovation when it occurs. The 
IDEAL Collaboration [31] has taken steps toward this goal. Based on a translation 
of the preeminent theory of diffusion of technological innovation [68] to surgery 
[79], the IDEAL framework divides the development and diffusion of SI into five 
stages. At each stage the innovation affects more patients, triggering a regulatory 
model and outcome measure (Table 2).
The IDEAL framework provides a template for regulating the development of 
innovations. Improvements to IDEAL have been proposed [9], including those relat-
ing to its definition of innovation. IDEAL defines innovation as “a new or modified 
surgical procedure that differs from currently accepted local practice, the outcomes 
of which have not been described and which may entail risk to the patient” [4]. Crit-
ics claim this definition is overly broad [40], fails to distinguish between variation 
and research, and lacks practical utility [70]. Since correctly identifying when inno-
vation is occurring is central to effective oversight, this is potentially a serious limi-
tation [33].
The Macquarie SI Identification Tool (MSIIT) addresses this limitation by opera-
tionalising a definition of innovation based on ‘newness’ [30]. MSIIT encourages 
surgeons to subjectively judge if they are innovating by considering whether the 
procedure/device is new, where ‘newness’ is defined by reference to the procedure/
Table 2  The IDEAL framework. Adapted from Lee [39]
IDEAL stage Stage 1 (idea) Stage 2a  
(development)
Stage 2b  
(exploration)
Stage 3 
(assessment)
Stage 4 (long 
term study)
Number of 
surgeons
Very few Few Many Many All eligible
Number of 
patients
Single to few 10s 100s 100s + 100s +
Ethical over-
sight
Informed 
consent 
only
Register protocols, 
local ethical 
approvals
Standard research 
ethics approvals
Standard 
research 
ethics 
approvals
Informed con-
sent only
Outcome 
measure-
ment
Case reports Prospective devel-
opment studies
Feasibility ran-
domised control 
trial
Randomised 
control trial 
or alterna-
tive designs
Registry, audit
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device’s difference from standard practice.4 The tool identifies relevant categories in 
which newness may occur. These are in relation to a device, tool or technique, and 
in each of these categories, may relate to use in patient groups, for indications, and 
in anatomical locations not previously associated with that tool, device or technique. 
The tool has a supplementary checklist including questions about prior evidence, 
publishability and preparation, all of which are also intended to help surgeons iden-
tify newness in their own practice.
That MSIIT is based on valuable conceptual research that sets it apart from previ-
ous ad hoc definitions. Nevertheless, the tool itself is open to four criticisms. First, 
using ‘new’ to define innovation appears to swap one indefinite term for a related 
indefinite term, since ‘Innovation’ is etymologically closely related to ‘new’.5 
Although this takes place at a high level and further specification follows, it is not 
clear what is gained by using the term ‘new’, rather than ‘innovation’, other than a 
change of terminology that seems vulnerable to some version of the Open Question 
Argument (i.e. it would still seem meaningful to ask ‘yes it’s new, but is it inno-
vation?’). Second, “no technology or its application is entirely new, as no inven-
tor works within a vacuum” [67]. Innovation may involve only small, incremental 
differences to normal practice [4, 59]. Even radically innovative devices and pro-
cedures are likely to have established components. What constitutes “newness” is 
subjective and susceptible to manipulation.6 While MSIIT attempts to limit this mal-
leability by focusing on specific categories of newness, within these categories new-
ness remains subjective, limiting the value of MSIIT to governance. While MSIIT 
seeks to clarify newness with examples, this obscures the question of whether new-
ness is an effective criteria for line drawing. We suggest it is easy to circumvent. 
Third, subjective newness is intentionally broad, so the tool measures many false 
positives and relies on the surgeon to identify which cases are mistaken. This passes 
the burden of identifying innovation to the surgeon (by asking them instead to iden-
tify what is new), thus undermining MSIIT’s aim of aiding practitioners. Finally, 
and importantly, it is questionable whether surgeons are the most appropriate people 
to judge innovation in their own practice. Research identifies surgeons as subject to 
various conflicts of interest [34, 44, 69]. Moreover, there appears to be little consen-
sus about what constitutes innovation among surgeons [66, 70]. One strategy being 
pursued by the Macquarie team [71] to mitigate this final criticism may be to ask 
theatre teams, rather than individual surgeons, to use MSIIT. Yet there remains a 
serious risk that team dissent will be squashed by workplace hierarchies that give a 
surgeon the final word.
Helping surgeons to identify innovation in their own practice appears laudable, 
as this could encourage the safe translation of innovation to practice by encourag-
ing effective evaluation studies. However, MSIIT is an incomplete response as, 
4 A similar, approach, based on subjectively defined newness was proposed by SAGES guidance on the 
subject published the same year. See: [76].
5 ‘Innovation’ and ‘new’ derive from the same Latin verb Novare (‘to make new’).
6 The successful efforts made by the manufacturers of the DaVinci surgical robot to establish ‘substan-
tial equivalence’ of their invention to existing technology is testament to this. See: [23].
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practically, we still require definitions—for effective governance and beyond7—to 
objectively identify innovation. For this reason, although indebted to the concep-
tual work that underlay MSIIT, we wished to step back from the MSIIT definition. 
We intended a conceptualisation of SI that transcended specific aims and agendas, 
to uncover the possibilities and commitments involved in formulating a variety of 
definitions to meet a variety of aims. Our approach to conceptualisation is discussed 
now.
Methods
While sometimes considered the foundation of philosophy, conceptualisation is a 
contested field [41]. Classical approaches to conceptualisation suggest that concepts 
comprise separately necessary and jointly sufficient features [32]. Yet, classical 
approaches to conceptual analysis have produced few (if any) satisfactorily defined 
concepts [80]. Experimental psychology indicates that the way humans approach 
concepts is not explicable using classical approaches. Instead, numerous stud-
ies indicate that some examples within a conceptual category are considered more 
typical of that category than others. For example, ‘sparrows’ are more readily cat-
egorised as ‘birds’ than ‘penguins’ [19]. Many agree [41, 43] that concepts are not 
definitions.8
Approach to Conceptualisation
While concepts are not definitions, conceptualisation can inform the development 
of definitions. Current paradigms, derived from psychology, suggest that concepts 
comprise hazy and overlapping features, none of which inevitably embody uni-
versally necessary and sufficient features.9 No candidate theory of concepts seems 
completely adequate,10 prompting radical reassessments of conceptualisation that 
include proposals to abandon concepts or consider concepts in pluralistic, rather 
than monistic, terms [41, 63]. In our view, the hazy, overlapping features that make 
up a concept mean that a concept can underwrite numerous, sometimes conflict-
ing, definitions. Conceptualisation can identify features of a concept, but further 
7 For example, researchers in our own project involved in identifying the scope and frequency of SI 
would be aided by a definition; more widely, policy-makers devising mechanisms for external oversight 
of innovation also require such definitions; publishers, peer reviewers and grant awarding bodies may 
also find such definitions useful.
8 For a lengthier overview of major criticisms of classical theory see [41] pp 79–83.
9 This clearly speaks to Wittgenstein’s analogy of e.g. likening conceptual features to fibres in a thread: 
“we extend our concept … as in spinning a thread we twist fibre on fibre. And the strength of the thread 
does not reside in the fact that some one fibre runs through its whole length, but in the overlapping of 
many fibres” [80] §67.
10 For example, the ‘prototype’ paradigm relies on the notion of a conceptual core, but cannot adequately 
explain the core’s structure. The ‘exemplar’ paradigm cannot explain why some features of exemplars 
are taken to be representative of category properties while others are not. The ‘theory’ paradigm has dif-
ficulty explaining why one person’s theory of a concept should be comparable to another’s.
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(including normative) work is then needed to determine which of those features 
can be brought together to form a definition for a specific purpose. Different needs, 
goals and normative presuppositions will result in different definitions, which bring 
together different features of a concept.11 We hypothesised, therefore, that it should 
be possible to conceptualise SI as features of SI qua SI, and draw on these features 
when developing future definitions for specific purposes. Our idea was that such a 
conceptualisation should contribute some underpinning structure to the different 
definitions of different policy-makers, researchers and practitioners. By undertaking 
a study of the ways SI, and innovation more broadly, is discussed by commentators 
in the literature, we intended to provide such a conceptualisation.
Our investigation began by synthesising the ways innovation is discussed in sur-
gery and a range of other disciplines. A conceptualisation so derived elucidates con-
ceptual areas of SI, but we reiterate that this was not to furnish a definition by pro-
viding the necessary and sufficient features of SI. Instead, our intention was to detect 
an undergirding conceptual structure.
Synthetic Method
Primary sources in the study of innovation are found in agricultural sociology and 
economics. Application of the concept to surgery brings in literature from not only 
surgery, but also bioethics, health policy and medical history in which SI features. 
As such, our method needed to sample literature from numerous fields of inquiry. 
We adopted Dixon-Woods et  al.’s [18] Critical Interpretive Synthesis approach, 
which takes a non-linear, iterative method of reviewing and analysing literature 
(Table 3).
Using keyword searches derived from the initial research question “How is inno-
vation and its phases (e.g. ‘evolution’, ‘stabilisation’, ‘adoption’, ‘abandonment/
rejection’) conceptualised and articulated, as they pertain to surgical innovation/
innovation in invasive interventions?” we derived a sample frame of 220 sources. 
Our initial searches excluded clinical research articles reporting surgical outcomes, 
reasoning these would not allude to the concept of innovation in a form amenable 
to analysis. Excepting this criteria, any sources that offered reasoned discussion of 
what innovation is were included (see Fig. 1).12
11 Within legal scholarship, Sinnott-Armstrong [74], from a similar standpoint, argues there are variety 
of types of definitions. Within his taxonomy his category of ‘precising definitions’ are definitions “that 
offer a precise use… linked to a practical purpose” (p 188). Rather than their accuracy, the success of 
such definitions, Sinnott-Armstrong maintains, is their utility to the particular purpose for which they 
are intended. We can thus see similarities with Sinnott-Armstrong’s work and our eliminativist position. 
Where we depart however, is that in our view that cleaving to the terms of a contested definition can 
cloud, rather than work for, the intended purpose.
12 The research protocol was registered with PROSPERO register of systematic reviews (ID 
CRD42017057492). The full protocol can be accessed at the following url: http://www.crd.york.ac.uk/
PROSP ERO/displ ay_recor d.php?ID=CRD42 01705 7492.
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Analysis followed the principles of theoretical sampling. A total of 72 sources13 
relevant to the developing line of enquiry were purposively selected from the sam-
ple frame and coded using the thematic method [11]. Purposive selection treated 
individual sources as research informants. Individual sources were selected because 
their title and abstract appeared to inform the emerging questions as they were per-
ceived by the authors at the time: thus we were guided at different times to, for 
example, bioethical accounts, practice descriptions, innovation theory and historical 
studies. The sample discussed, and sometimes defined, innovation, but for the most 
part made no specific claim about the content of the concept of SI. Indeed, even 
where sources did make such claims we did not take such assertions merely at face 
value. Instead we took a critical approach and coded all parts of the discussion that 
pertained to the nature of innovation to reveal the structure of the underlying con-
cept without imposing any further normative screen on the results. We reasoned this 
was a legitimate interpretation of the Critical Interpretive Synthesis approach, which 
we had adopted precisely because of the indistinct nature of SI and the numerous 
competing definitions and claims that surround it. Throughout the analysis, all 
authors discussed the developing codes, areas needing additional investigation, and 
outcomes of analysis.
Analysis: Developing the Concept
Our study suggests 5 conceptual areas pertaining to SI (Table  4). For clarity, it 
is worth reiterating here that these conceptual areas do not themselves constitute 
Table 3  Critical interpretive synthesis. Adapted from Dixon-Woods et al. [18]
Although non-linear and iterative, critical interpretive synthesis could be understood to follow these steps
Step Sub-step
1. Using a broad, provisional research question, 
undertake a literature search
2. Gather identified papers into a sampling frame
3. Iteratively select sources from the sample frame, 
review and extract data
(a) Sources are purposively selected from the 
sample frame using principles of theoretical 
sampling (e.g. contribution to research goal); 
fatally flawed studies are discarded
(b) Extract data using the thematic method to 
develop codes for key arguments and phrases 
and theories; cluster codes into themes
(c) Continue theoretical sampling, data extrac-
tion and theme development until theoretical 
saturation
4. Synthesize arguments from the themes, integrat-
ing these with existing evidence
13 The full list of the sources is available from the corresponding author on request.
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a definition of any sort. Instead they are facets of a rich—and, we will argue, not 
entirely coherent—concept of SI. Detailed analysis of these conceptual areas is 
given below.
1. “Purpose”: Drivers of Innovation
Studies explored the drivers of SI, suggesting that SI may be undertaken due to 
patient, surgeon or industry needs or desires. This category also raises the question 
of whether demand is created by innovations or vice versa.
Responding to Patient Needs or Wants The interests of patients, surgeons and 
industry may to some extent overlap, making clear distinctions about what drives 
innovation is problematic. Nevertheless, the literature identifies a number of differ-
ent drivers. Some suggests that patient wants and needs are drivers of SI [7]. These 
motivations encompass usually bifurcated positions in economic analyses of innova-
tion. Some economists see demand for innovation as being created by the innovator, 
Fig. 1  Literature search flowchart
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in what is termed “technology push” [28]. Others see innovation as a response 
to external or public demand [58]. Likewise, wants and needs can arise from the 
patient or be identified by the surgeon (who we consider in due course). In relation 
to patients, wants and needs are (sometimes) distinct: a want will exclusively arise 
from the patient, whereas a need may be identified by the patient or a third party. 
Barkun et  al. consider patient need to often lie at the root of SI [4], a motivation 
expressed by surgeons themselves [15]. Meyerson argues that patients who demand 
it have a right to innovative surgery in terminal illness if there is some evidence of 
effectiveness [53], which suggests innovation satisfies wants. Wants and needs need 
not be distinct, although they are often ranked, with needs putatively taking prior-
ity over wants in emergency treatments [35].14 Outside the bounds of emergency 
experimental treatment, wants may take precedence. Wants are often identified in 
discussions of medical innovation. Public demand, a corollary of want, is identified 
as a driver for medical innovation in some analyses [1, 6, 51]. McKinlay argues that 
public demand, stimulated by media reports, places pressure on funders to ensure 
that innovations are widely available [49]. On this reading, public demand plays a 
role in the diffusion of medical innovation, but the innovation originates prior to this 
demand.
Surgeon and Industry Demand In surgery, demands may come from patients, 
industry, or arise from surgeons. Surgeons may want to perform a procedure more 
efficiently or quickly in order to meet their own or institutional need, or they may 
want to build their career as an ‘innovator’—and this may or may not coincide 
with responding to patients’ needs. The introduction of innovative devices appears 
largely driven by industry, based on a desire for market share, and can be imita-
tive of existing devices [34, 59]. Such analysis suggest that it could be the wants 
of industry or surgeons that are served by these technologies, with public need a 
peripheral (or even absent) focus. It is possible therefore that neither the wants nor 
the needs of the public are directly important to SI, but that SI plays an economic 
Table 4  Themes and descriptions
Theme Conceptual area Description
Purpose Drivers of innovation Where does innovation come from, to what should innovation 
respond?
Place Context of innovation What is the relationship between innovation and research, early 
adoption and routine variation and/or it’s geographical place?
Process Differentiating innovation How does the innovation depart from standard approaches or 
outcomes?
Product Consequences of innovation What are the (in)tangible results of the innovation?
Person Identity of innovator Who is the innovator, what are their character traits and inten-
tions?
14 The claim from these authors utilises both wants (informed consent) and needs (no alternative), but 
prioritises the latter.
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or career-enhancing function. Some suggest there is something morally problematic 
about this orientation [66],15 which may provide a reason to define innovation in a 
particular way for the purpose of governance.
In summary, the role of wants and needs of various parties suggests that “Pur-
pose” is a conceptual area of SI. Definitions of SI may thus take a position on how—
if at all—the drivers of an activity feeds into whether it is treated as innovation or 
not, and why this is the case.
2. “Place”: Context of Innovation
The concept of SI also pertains to where—contextually and geographically—inno-
vation is held to take place. Debates about context largely turn on the relationship 
between innovation and research, with a subsidiary debate about whether premedi-
tated variations constitute innovation or research.
Geographical Place Discussion of geographical place is limited to whether diffu-
sion of a SI to a new a location should [4] or should not [30] play a part in identify-
ing SI. Studies demonstrate isolated instances of adoption may occur when a proce-
dure is well-established within surgery at large [20].16 A learning curve is associated 
with the journey from novice to expert in a particular procedure [24]. The learning 
curve results in relatively poor performance when an innovation is first adopted [12]. 
A new geographic location that entails changes of personnel therefore impacts on 
patient safety, which may be an important focus for oversight when defining SI. If 
safety is less important, it is conceptually simpler to discount new locations from a 
definition of innovation. Tying innovation to first time use of all or part of a proce-
dure captures each first time use of established procedures, identifying all early and 
late adopters as innovators in a way that could problematically impact on govern-
ance by inundating governance structures with low-risk cases and burdening prac-
tice with disproportionate levels of scrutiny.
Different to Research? As a contextual feature, whether innovation is or is 
not distinct to research is extremely important. If it is indistinct, then the label of 
innovation is a mere flag of convenience to avoid scrutiny. If it is not, then it rep-
resents a lacuna that is insufficiently considered by current governance structures. 
The literature is divided on whether innovation is equivalent to, or distinct from, 
research. While acknowledging that research may follow innovation, many distin-
guish research activity from SI [2, 3, 16, 21]. Others consider SI to be research [40, 
52, 65].17 Some accept the ambiguity of one or both terms without drawing any firm 
conclusions [10, 44].
16 The approach taken to geography will reflect whether innovation is subjectively or objectively 
defined, a question we broach below.
15 The possibility of a prudential benefit to society in allowing industry to make profits or surgical 
careers to flourish is a potential contradiction to this position. Our (anonymous) peer reviewer argues this 
seems a false dichotomy: surgical careers can flourish in the absence of large royalty and other payments 
from device manufacturers and most industries survive without the enormous profits generated in the 
biomedical field. (We are not committed to either position.)
17 Identifying innovation as research may not produce clarity: Margo uses the term “informal” research 
[42], a term that apparently acknowledges the ambiguous status of both innovation and research.
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If the status of innovation vis research is ambiguous, whether an activity is 
labelled by a surgeon as innovation or research is merely a choice of terminology 
and may be driven by a desire to avoid the burdens accompanying research [40] or 
access benefits accompanying ‘innovation’.18 These burdens differ between jurisdic-
tions: for example, U.S. insurers will not pay for ‘experimental’ therapies [44],19 
while the UK government encourages ‘innovation’ [17].20 Some argue that exist-
ing definitions of research (which emphasise generalisable theories and principles, 
scholarship and hypothesis testing) ill-describe innovation [40, 45]. Indeed, rather 
than hypothesis testing, some associate innovation with hypothesis generation [50]. 
Extending the idea that an innovation is performed specifically to benefit a single 
patient, some argue that innovation does not produce generalisable knowledge [35, 
73]. However, as knowledge gained from each patient encounter is likely to be used 
in others, this also appears a shaky distinction. Other popular definitional criteria for 
research are also used to distinguish innovation [13]. Spontaneity allegedly distin-
guishes innovation from research, which is presumed to be premeditated [67, 73]. 
Some argue that surgical practice frequently necessitates ‘routine variation’, where 
spontaneous changes in practice take place in response to anomalies in patient anat-
omy [8]. These authors, like the surgeons in a survey by Reitsma and Moreno [66], 
suggest that routine variation is a feature of normal surgical practice, not research. 
Attempting a paradigm shift, Lotz argues that this (and other) intrinsic features of 
surgery make all surgery research [40].
The relationship of SI to research, routine variation and standard practice remains 
contested. If safety issues inform whether something is defined as innovative, then 
that definition may need to attend to many other aspects, such as the learning curve, 
and thus geographical place. Definitions may also consider ‘place’ in terms of con-
text and, depending on the aim of the definition, either choose a definition that dis-
entangles innovation from research or a definition that makes innovation part of a 
research process. Any of these options might be justified but will imply different 
kinds of governance.
3. “Process”: Differentiating Innovation
The concept of SI includes consideration of how innovation is achieved, which may 
be characterised as a process, a discrete event, or combinations thereof. SI may, 
therefore, involve a one-off event or a series of events (and revisions), with the lat-
ter resembling a process. However it is achieved, if the process/event of SI is to be 
distinguished, it must have features, like impact or newness, that mark it as different 
from the process/event of normal surgical practice.
Nature: Process or Distinct Event? Perhaps due to their differing aims, the 
MSIIT and IDEAL implicitly take different approaches to the development of SI. 
18 This speaks to one of the conflicts of interest encountered by the subjective determination of SI 
favoured by the MSIIT.
19 Assuming, as this author does, that ‘experimental therapies’ equate to ‘innovation’.
20 They perhaps assume that innovation is done with appropriate arrangements and procedures in place.
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MSIIT, in searching for criteria that can prospectively distinguish routine variations 
and introduction of new procedures to new geographical locations from SI [30], pre-
suppose a distinctive timepoint where innovation occurs. IDEAL, by adapting an 
existing model of technological innovation to SI, focuses on an ongoing process of 
SI that includes development and diffusion of the innovation into the mainstream. 
That this dichotomy is most credibly due to the differing aims of MSIIT and IDEAL 
is borne-out by comparing other areas where it occurs. While not always consid-
ering SI (rather than medical innovation more broadly), the distinctive aims of 
legal treatments of innovation mean they tend to focus on distinct time-points of 
innovation [13, 38], while attention to the learning curve and the spread of inno-
vation in the surgical literature (in general) means that innovation tends therein be 
considered a process [24]. While unintentional, studies indicate epistemic costs 
to both approaches. A model of innovation based on process implies “more order 
and coherence exist than is actually the case” [49]. Similarly, conceiving innova-
tion as an event fails to account for the relationship of imitation, reinvention and 
iterative change to innovation. These relationships seem important: Schumpeter’s 
economic theory asserts that successful innovations result in imitation [28]. Rogers’ 
sociologically based theory of innovation views reinvention as part of the dynam-
ics of adopting technological innovations [68]. Descriptions of SI arising from the 
IDEAL framework, including within (rare) descriptions of developing a SI [75], 
suggest iterative changes play an important role in the process of innovation [4]. 
Iterative change is also germane to the notion of ‘enabling technologies’—existing 
innovations whose dissemination allows further innovations to arise [67]. Iterative 
change suggests that the line between producing and adopting a SI may be fuzzy, 
and underlines the point that the way we choose to define innovation will involve 
both gains and losses to clarity [49]. Moreover, how iteration of innovation is con-
ceived may affect the level of governance that the innovation receives. For example, 
Schwartz proposes that a single instance of innovation should not require oversight, 
but repeated instances should [73].
Features: Departing from Existing Standards The literature generally argues that 
SI must differ from what occurs in surgery on an everyday basis. The 1978 Belmont 
report on research ethics suggests that medical innovation occurs “when a clinician 
departs in a significant way from standard or accepted practice” [57]. This type of 
formulation is commonly repeated.21
One frequent way this difference is characterised is as ‘newness’, or similes such 
as ‘novel’ or ‘first’ [21, 30, 48, 73]. As noted above, classifying newness is subjec-
tive. All new surgical procedures will be composed of basic techniques (e.g. dis-
section) which are not themselves new. Moreover, depending on whether iteration 
is included in a characterisation of SI, new techniques will (perhaps always) build 
on previous ones, creating an area of discretion between modification and ‘abso-
lute’ newness. Additional terms may address this imprecision. For example ‘new 
21 For example, SI “differs from the standard technique” [30] p 951; “differs notably from the existing 
standard of care” [66]. Process differences that have been proposed to include patient time on anaesthesia 
[8]; different (additional) consent [70]; different technique, equipment, or patient group [30].
 Health Care Analysis
1 3
combinations’, was proposed by the economist Joseph Schumpter as a loose, catch-
all definition of innovation [72], and this approach has been utilised in some defi-
nitions of SI [21, 30, 44, 64]. Other discussions use terms of magnitude such as 
‘major’ or ‘significant’ [56, 64] to avoid too “broad and blunt” a definition of inno-
vation [40] Hutchison et al. caution that such modifiers are ambiguous and should 
only be used with clear guidance about their intended interpretation [30]. Thus we 
can see a tension between inclusive and exclusive modifiers: every extra modifier 
threatens ambiguity, yet each absent modifier increases the chances that a definition 
will be overly broad and thus swamped with positives.
Within this conceptual area, thought must be given to whether a definition aims at 
breadth or precision, and to which compromises to accuracy are acceptable. Defin-
ing SI as a process may exclude details to increase intelligibility and simplicity, 
while a definition that favours a distinct event must be clear about how iteration is 
explained and/or excluded.
4. “Product”: Consequences of Innovation
The concept of SI includes any products of SI. Narrowly construed this product may 
simply be the surgical procedure or instrument itself. However, commonly the prod-
ucts of an SI include (some or all of) the consequences of the innovation. Conse-
quences might be tangible, like patents, or intangible, like risk. To some degree a 
discussion of consequences may overlap a discussion of the drivers of innovation 
(our theme of “Purpose”) as particular consequences may be assumed in embarking 
on innovation. Nevertheless, we feel that consequences are more coherently consid-
ered as a theme in their own right,22 and the overlap here reinforces the aptness of 
Wittgenstein’s analogy between a concept and a rope comprising multiple overlap-
ping threads.
Tangible Products Tangible products, such as patent or the prospect of publica-
tion have been associated with SI [8, 29], including by surgeons themselves [70]. 
Since patent/publication will tend to exclude failed innovations, focus on these prod-
ucts supports the view that SIs are, by definition, successful [7]. Moreover, at least 
in the case of patent, this employs a somewhat circular reasoning that a legal frame-
work for patenting can be a shortcut to defining innovation, which we feel reads too 
much certitude into the patenting process. A second class of tangible products are 
socio-economic impacts. In economics, Schumpeter defined innovations as neces-
sarily disruptive of the current economic equilibrium [72], Socio-economic impact 
of SI is not uniform, and some authors distinguish between the most impactful (dis-
ruptive) and least impactful (incremental) innovations [21, 30, 67]. Arguably, identi-
fying disruptive innovations is important to definitions aimed at historical, economic 
or social evaluation of SI.
22 To a lesser extent the same could be true of the theme of “person” and “product”, given that intention 
plays a part in the analysis of both.
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Uncertainty Intangible products such as risk are commonly associated with SI [8, 
40, 73].23 Although Rogers et al. argue that innovations may sometimes reduce risks 
[70], new occurrences that diverge from the norm introduce uncertainty, suggesting 
that risk—of some magnitude—may be a persistent feature of SI. Discussions often 
view risks as proxies of harm, however the flip-side of this is to argue that benefit 
is the defining product of SI. This benefit may be characterised abstractly or indi-
rectly—such as in terms of producing knowledge [40, 56].24 Alternatively, benefit 
may be characterised in specific and direct terms, for instance benefiting a particular 
patient who undergoes the SI [70]. While benefit may suggest more confidence in 
the product of the SI (and thus less unpredictability) than risk, uncertainty remains. 
When and where benefits or risks transpire relates to the account adopted about the 
process of SI. If SI is a distinct event, the benefit or harm might also be a distinct 
event, while, on a process account, several intended benefits or harms may occur at 
distinct phases in the career of the same SI. Importantly, not all ‘innovative’ prod-
ucts may produce any risks or benefits. Some commentators are sceptical of the pre-
sumption that medical innovation does or will produce benefits on every occasion 
[49], and benefits are not included in wider definitions of technological innovation 
[68]. Similarly, innovation need not introduce extra risk. Standard business mod-
els of surgical instrument manufacturers involve the production of so-called ‘me-
too’ products [59].25 Arguably, these minor modifications may give a (patentable) 
impression of difference without changing the risk profile. Nevertheless, even minor 
differences will introduce new uncertainties (for example, just changing the colour 
of an instrument might cause it to be misrecognised). The conviction that the prod-
ucts of SI are unpredictable unifies these perspectives.
While consequences are by their nature unpredictable, some observe that risks 
and benefits of SI cannot be known prospectively; [30] indeed, decades may elapse 
before such information is completely clear [12]. Others suggest that risks of SI may 
nevertheless be reasonably estimated, for example by considering similar, estab-
lished procedures [54]. Indeed, some argue that, rather than actual outcomes, dif-
ferences in expected outcomes are markers of innovation [73]. A definition of SI 
intended to be prospectively applied might therefore exclude consequences from a 
definition of innovation, as (at least partially) does MSIIT, or find an acceptable way 
of prospectively estimating risks and benefits. A concept of SI includes any tangible/
intangible products that arise from SI, including socio-economic impact, benefits 
and risks. Definitions employing such terms require appropriate methods for assess-
ing these impacts to be identified. Clearly tangible products are easier to measure in 
this respect. How definitions approach “Product” will be affected by their intended 
use: for example, whether they identify SI prospectively or retrospectively, intend 
to enhance patient safety, underwrite patentability or recognise socio-economic 
events. Because of the prominence of unpredictability in this conceptual area, the 
24 This potentially collides definitions of innovation with definitions of research.
23 More general indications of risk and uncertainty, like ‘untested’ and ‘nonvalidated’ are also used to 
discuss SI, e.g. [7, 52].
25 Me-too products are also found in medical innovation [51].
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risk profile will arguably feature heavily in definitions aimed at enhancing patient 
safety, but may be less important for other purposes such as identifying historical 
innovations.
5. “Person”: Identity of Innovator
The identity of the innovator in SI is conceptually significant given the prevailing 
model of innovation (on which IDEAL is based), and the frequency with which 
surgery and surgeons are identified as innovative. Further, the conceptual area of 
‘person’ includes questions of intention central to whether definitions identify SI as 
subjectively or objectively determined.
Personal Characteristics Rogers’ influential sociological theory of the spread of 
technological innovation explicitly categorises innovators and adopters according 
to personal characteristics. These include those related to socioeconomic status and 
“personality variables” including empathy, rationality, and intelligence that Rogers 
collectively terms ‘innovativeness’ [68]. Rogers’ theorises that the most innovative 
members of any population (“innovators”) comprise an elite 2.5% of a target popu-
lation [68]. Rogers’ laudatory approach to innovator character is similar to Schum-
peter’s “heroic” risk-taking entrepreneurs in economics [28]. Emphasis on positive 
innovator character has been questioned in agricultural sociology [77], however the 
surgical literature frequently asserts the special personality of innovators and/or sur-
gery as an intrinsically innovative discipline. Some repeat Rogers’ suggestions about 
personal characteristics in the context of SI [14]. Others identify surgeons’ personal-
ity traits [47] including affinity to new technology [67], compassion [64], consci-
entiousness [52] and dedication to science [69]. Surgical culture claims a unique 
affinity between surgeons and innovation [44]. SI also has a putative relationship to 
expertise. Since SIs are claimed to be difficult procedures [48], or at least requiring 
expert knowledge, innovators are often identified as expert surgeons [30, 73].26 Nev-
ertheless, innovation is not always synonymous with expertise. Cardiac catheriza-
tion was innovated in humans by a novice surgical trainee [78].27 Historically, Ben-
David argues expert scientific cultures have been antagonistic to innovation [5], and 
some commentators identify the conservative nature of surgical practice as a block 
on SI [67].
Intention The intention of the surgeon is also, often, noted in discussions of SI, 
underlining the connection of innovation to debates about what constitutes research, 
where intention is also considered important [13]. Some allege that the intention to 
benefit a current patient and to benefit future patients respectively distinguish innova-
tion and research [52, 73]. A darker view of intention is taken by Reitsma and Moreno 
[65] who imply that many surgeons willfully avoid outside scrutiny. Others argue that 
surgeons are subject to unconscious biases hampering their ability to scrutinize their 
own intentions [69]. Difficulties objectively identifying intention affect the status of 
26 The necessity to reskill is flagged as a potential mark of SI suggesting that attention to the expertise of 
the surgeon distinguishes innovators from early adopters. See: [70].
27 Forssmann published the result of self-experiment in his first year after graduation. See: [60].
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SI as something that can be identified subjectively or by any neutral observer. Much 
of the current use of SI suggests it is subjectively identified, and MSIIT tends toward 
this, albeit open to an intersubjective, team-based, approach [30].28 Subjective deter-
mination of innovation raises the potential for independent origination of similar 
innovations. Because this may result in two surgeons unnecessarily performing the 
same risky SI, taking innovation to be subjectively determined requires strong safe-
guards to prevent unnecessary (and hazardous) replication. Such a conceptualisation 
of innovation thus appears as a strong motivator to establish registries of innova-
tion—a widespread aspiration in the literature [40, 62, 73]. Laissez-faire approaches 
to the regulation of SI predominate in the literature [36] and defining SI subjectively 
provides a strong impetus to this laissez-faire approach. Ultimately, the specific aims 
of the defining party will determine how this conceptual area is addressed. Defini-
tions aimed at protecting current surgical practice may define SI subjectively, while 
those aiming to alter practice may define SI using a more observer-neutral approach.
As with the preceding areas, the approach to this conceptual area will be guided 
by the aims of a definition. Definitions aimed at sociological studies of surgeons 
may concentrate on personological descriptions of surgeon innovators, while defini-
tions aimed at safety may seek define innovation objectively and independently of 
the person.
Discussion
The analysis we have presented from our Critical Interpretive Synthesis has two dis-
tinct uses that we will consider in two main sections in this discussion. In the first we 
offer a conceptual structure for future definitions of SI. The second section discusses 
our increasing scepticism about the usefulness of SI as a concept, that has led us to 
question the salience of a definition that claims to identify every instance of SI. Thus, 
the second section of our discussion presents our analysis as evidence that future 
studies should take an eliminativist approach to identifying SI. By this we mean that, 
in inquiries that investigators intuit to be about SI, rather than attempting to define SI, 
the more important and useful task is to determine what role the term ‘innovation’ 
would play in one’s inquiry, and then to devise specific definitions that identify the 
surgical activity pertaining to that area. Our broad motivation for this conclusion is 
that the term SI appears to carry a great deal of ambiguous conceptual baggage that 
can only serve to obfuscate and avoid scrutiny of the development of surgical prac-
tice.29 We acknowledge that this is a radical solution with which not all will agree, 
but which does, at the least, demand reasoned objection. We thus begin with a con-
ceptual structure—or toolkit—that may be useful in devising future definitions of SI.
28 A subjective definition of ‘new to the individual’ is used by Everett Rogers in his theory of techno-
logical innovation [68].
29 We openly acknowledge here that our own normative concerns that give rise to this criticism are (1) 
there is insufficient monitoring and reporting of surgical practice, leading to potential for significant 
patient harm, and (2) overly restrictive governance has the potential to stifle beneficial developments in 
practice.
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A Conceptual Toolkit
There will never be one single definition of SI, but rather numerous definitions 
designed for numerous purposes. The five themes of purpose, place, process, prod-
uct and person relate to conceptual areas that constitute a conceptual toolkit to help 
ensure a definition is justifiable at a structural level, and carefully considers what it 
needs from each conceptual area. Each of these conceptual areas require considera-
tion when devising a definition of innovation. A collection of non-exclusive ways 
that these elements could be resolved into a definition is given below. For clarity 
we reiterate that these are not intended to be examples of necessary and sufficient 
features, and we are not proposing a definition. Indeed, some of the elements would 
be contradictory if taken together. Rather, in Fig. 2, we illustrate a range of possible 
claims that could be made under each conceptual area, and which might be selected 
from to build a definition of SI.30
Potentially such a toolkit could inform what ought to be reported when infor-
mation about surgical techniques or equipment is shared. Numerous commentators 
have proposed (sometimes compulsory) formal registries of SI [34, 55, 59, 61]. 
30 The figure is intended to be indicative, rather than exhaustive. Rather than summarise the implications 
of any or all of these claims, we refer the reader back to the full descriptions of the themes.
Purpose
The purpose of 
innovave 
treatment or device 
is to respond to 
these drivers…
•Public demand
•Paent needs
•A challenge
•An emergency
•Efficiency needs
•Market share 
needs
Place
Innovaon occurs 
when a treatment 
or device is used in 
these contexts…
•A new jurisdicon
•A new instuon
•A new team
•Research contexts
•Normal pracce
Process
Innovaon is 
different because it 
occurs through…
•Isolated events
•Repeated events
•Iterave changes
•Linear processes
•Deparng from 
norms
•New actvies
•New 
combinaons
•Major changes
Product
Innovaon results 
in consequences 
like…
•Patent and 
publicaon
•Unpredictable 
results
•Un/changed risks
•Benefits to a 
parcular paent
•General benefits 
to paents
•Success
•Incremental 
changes
•Revoluonary 
changes
Person
The person 
innovang…
•Is not risk averse
•Is dedicated
•Possesses 
invovaveness
•Is an expert
•Is an outsider
•Devises the 
innovaon
•Adopts the 
innovaon
•Intends to innovate
•Intends to do good
•Intends to avoid 
scruny
Fig. 2  Ways conceptual areas could be resolved
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Registries are widely supported in the literature [25, 39].31 Some registries exist, 
but they are not always well used [39]. Registering innovation presents a practical 
problem since innovation is not well defined. Presuming some agreed definition of 
SI is desirable and possible, the transparency and usefulness of entries to a register 
may be increased by reporting information related to purpose, place, process, prod-
uct and person.32
An Eliminativist Approach
As we stated at the outset of this article, our primary purpose is improving the 
evaluation and regulation of surgical practice. While a conceptual toolkit of the sort 
presented above was our original intention, we were unprepared for the breadth of 
potential definitions a conceptualisation would support, and this might impact on 
our primary purposes. The nature of each conceptual category allows diametrically 
opposing interpretations, and our analysis shows that at least some of these opposing 
interpretations are apparent in the literature. Further, many of the conceptual areas 
would not be needed for our own, regulatory, purposes. This again underscored 
the scope for dissimilar definitions of a putatively similar phenomenon in different 
disciplines. For instance, the “Purpose” of a SI might be of interest to social sci-
entists, but be of little help in identifying innovation for regulatory purposes. The 
context variability was particularly true of the fifth conceptual area, “Person”. The 
frequency with which the various claims of the affinity of surgeons and surgery to 
innovation and the regularity of commentary that claimed that intention was a key 
feature of innovation meant that the person-centred conceptual area appeared impor-
tant to SI. Nevertheless, a focus on the innovator, and the implications this has for 
the subjective determination of SI by the surgeon, seemed to work against the (to 
us compelling) arguments for the need for external oversight and regulation of SI 
to ensure patient safety. It is also notable that not all of these conceptual areas had 
discriminatory power. Despite them being common themes that run through the dis-
cussions of innovation we examined, many had much in common with other types of 
healthcare interventions. We reasoned that such lack of distinction may be because 
innovation itself is not distinguishable from much of healthcare. Since so much that 
was needed to conceptualise SI was either not needed for our purposes, seemed to 
obfuscate the activity we had intended to identify, or was common to healthcare 
practice, our conclusion is that an eliminativist approach to SI would be more effec-
tive. By effective, we mean that an eliminativist approach would reduce the chances 
that regulation could be misinterpreted (willfully or otherwise) or misunderstood, 
thus ensuring a more stringent approach to evaluation and regulation focused where 
(we argue) it is most needed. This approach stemmed from the view that SI was 
too hopelessly laden with conceptual baggage to be useful in bioethical discourse. 
31 Indeed, an explicit aim of the IDEAL collaboration is to improve the reporting of SI, by facilitating a 
registry of operations that are first-in-human [46].
32 As entries are aggregated, convergence in reported criteria would potentially populate a fully fleshed 
description of SI that would inform multiple fields of inquiry.
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By ‘eliminativist’ we do not mean erasing innovation from language altogether—
we agree this would be undesirable and likely impossible given such language is 
entrenched in surgery. “Innovation” will retain some, primarily rhetorical, uses. But 
we should call out the essential meaninglessness of the term in serious discourse 
aimed at evaluation and regulation. In these areas, we should consider what it is 
about surgical activity that needs attention and develop robust definitions to identify 
these areas. For example, our own concern is that some surgical activity needs to be 
safer and more transparent. Given that focus, what seems important to us is both the 
need for surgical activity to be transparent to third-parties, and (lack of) knowledge 
about the safety and efficacy of a subset of surgical activities (that may otherwise 
be labelled as SI). This focus suggested our definition should therefore be objective 
and should not rely on the probity of individual surgeons to self-report. Rather, it 
should concentrate on identifying how much is prospectively known about the safety 
and efficacy of a procedure.33 This requires analysis of the extent an intervention 
presents a substantially new risk profile because of its difference from existing inter-
ventions, to what extent a risk profile can be anticipated because components of the 
intervention are tried and tested, and what new risks arise from any hitherto untried 
combination of these components. Governance should therefore focus on assessing 
risk, appropriate methods for studying changes to surgical practice according to its 
risk profile, and the appropriate reporting of outcomes. We can therefore jettison 
the language of innovation, which by being all things to all people provides cover 
for both misunderstanding and wilful avoidance of scrutiny, and instead focus on 
the need to regulate for the reporting and monitoring of any planned or unplanned 
changes to invasive surgical procedures that result in an uncertain risk profile. This 
is no small task itself, but it is made simpler now that we have rejected the con-
ceptual baggage that comes with ‘innovation’ and can focus exclusively on what is 
important to our aims of improving transparency and safety. Our suspicion is that 
other studies would benefit from the clarity that taking this eliminative approach can 
bring.
Conclusion
SI raises numerous ethical and practical questions that suggest it requires greater 
oversight. Despite the progress that has been achieved in this field, the absence of 
robust definitions frustrates this purpose. We observe that the definition formulated 
by the MSIIT study serves specific purposes that make specific (and questionable) 
assumptions about the probity of surgeons and the nature of innovation. A prospec-
tive definition to be used by surgeons is only one of many types of definition that 
33 The question could be raised about how our own definition will avoid these problems. This is a valid 
question (although not one that invalidates our critique). Briefly, our response is that not all concepts 
are as cluttered or contested as innovation, and thus there may be more common ground in a definition 
based on risk and sufficiency of knowledge. We plan to offer such arguments more thoroughly in a future 
worked explanation of our definition in a separate article.
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may be useful to the aim of the safe translation of SI into everyday practice. Our 
conceptual study synthesises a range of sources, concluding that the concept of 
SI includes information about these conceptual areas; the drivers and purpose for 
which innovation is undertaken; the contextual and geographical place where the 
innovation is undertaken; attempts to differentiate innovation from other processes; 
its tangible and intangible products and consequences, and; the viewpoint and per-
sonal traits of the person who innovates. While potentially elucidating definitional 
criteria, these are so broad as to allow numerous dissimilar definitions of SI. These 
may further obfuscate and complicate oversight of SI. We therefore, for the purpose 
of evaluation and governance of surgery, propose an eliminativist approach. Instead 
of seeking to formulate a universal definition of SI, this approach focuses on the fea-
tures of the surgical activity that we consider to be in need of scrutiny and develops 
robust definitions to identify these. Such an approach is both simple and effective, 
and ultimately will benefit both patients and surgeons.
Acknowledgements This study was supported by the NIHR Biomedical Research Centre at University 
Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this pub-
lication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health 
Research or the Department of Health. The authors would like to thank Dr Kerry Avery, Miss Natalie 
Blencowe, Dr Sian Cousins, Prof Rob Hinchliffe Mr Barry Main and Mr Angus McNair of the University 
of Bristol’s Centre for Surgical Research for their input into discussions that led to this article.
Funding This study was funded by the NIHR Biomedical Research Centre at University Hospitals Bristol 
NHS Foundation Trust and the University of Bristol (Grant Number BRC-1215-20011).
Compliance with Ethical Standards 
Conflict of interest JB is a member of the IDEAL Executive Group. GB, JI and RH declare that they have 
no conflict of interest.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 Interna-
tional License (http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, 
and reproduction in any medium, provided you give appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons license, and indicate if changes were made.
References
 1. Acemoglu, D., Cutler, D., Finkelstein, A., & Linn, J. (2006). Did medicare induce pharmaceuti-
cal innovation? American Economic Review, 96(2), 103–107. https ://doi.org/10.1257/00028 28067 
77211 766.
 2. Agich, G. J. (2008). The ethical challenge posed by surgical innovation. Lahey Clinic Medical Eth-
ics, 15(2), 1–2.
 3. Ahmed, A. S. (2005). The last twist of the knife: Encouraging the regulation of innovative surgical 
procedures. Columbia Law Review, 105(5), 1529–1562.
 4. Barkun, J. S., Aronson, J. K., Feldman, L. S., Maddern, G. J., Strasberg, S. M., & Collaboration, 
Balliol. (2009). Surgical innovation and evaluation 1 evaluation and stages of surgical innovations. 
Lancet, 374(9695), 1089–1096.
 5. Ben-David, J. (1960). Roles and innovations in medicine. American Journal of Sociology, 65(6), 
557–568.
 Health Care Analysis
1 3
 6. Bender, S., Flicker, L., & Rhodes, R. (2007). Access for the terminally ill to experimental medi-
cal innovations: A three-pronged threat. American Journal of Bioethics, 7(10), 3–6. https ://doi.
org/10.1080/15265 16070 16722 55.
 7. Bernstein, M., & Bampoe, J. (2004). Surgical innovation or surgical evolution: An ethical and prac-
tical guide to handling novel neurosurgical procedures. Journal of Neurosurgery, 100(1), 2–7. https 
://doi.org/10.3171/jns.2004.100.1.0002.
 8. Biffl, W. L., Spain, D. A., Reitsma, A. M., Minter, R. M., Upperman, J., Wilson, M., et al. (2008). 
Responsible development and application of surgical innovations: A position statement of the Soci-
ety of University Surgeons. Journal of the American College of Surgeons, 206(6), 1204–1209. https 
://doi.org/10.1016/j.jamco llsur g.2008.02.011.
 9. Blazeby, J. M., Blencowe, N. S., Titcomb, D. R., Metcalfe, C., Hollowood, A. D., & Barham, C. P. 
(2011). Demonstration of the IDEAL recommendations for evaluating and reporting surgical inno-
vation in minimally invasive oesophagectomy. British Journal of Surgery, 98(4), 544–551. https ://
doi.org/10.1002/bjs.7387.
 10. Bracken-Roche, D., Bell, E., Karpowicz, L., & Racine, E. (2014). Disclosure, consent, and the 
exercise of patient autonomy in surgical innovation: A systematic content analysis of the concep-
tual literature. Accountability in Research-Policies and Quality Assurance, 21(6), 331–352. https 
://doi.org/10.1080/08989 621.2013.86604 5.
 11. Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in 
Psychology, 3(2), 77–101. https ://doi.org/10.1191/14780 88706 qp063 oa.
 12. Broberg, C. S., Shen, I., Menashe, V., & Starr, A. (2017). Emergence of the arterial switch pro-
cedure for transposition of the great arteries and the potential cost of surgical innovation. Jour-
nal of Thoracic and Cardiovascular Surgery, 154(3), 1047–1051. https ://doi.org/10.1016/j.jtcvs 
.2017.03.035.
 13. Chan, T. E. (2013). Legal and regulatory responses to innovative treatment. Medical Law 
Review, 21(1), 92–130. https ://doi.org/10.1093/medla w/fws02 5.
 14. Cundy, T. P., Marcus, H. J., Hughes-Hallett, A., Najmaldin, A. S., Yang, G. Z., & Darzi, A. 
(2014). International attitudes of early adopters to current and future robotic technologies in 
pediatric surgery. Journal of Pediatric Surgery, 49(10), 1522–1526. https ://doi.org/10.1016/j.
jpeds urg.2014.05.017.
 15. Danjoux, N. M., Martin, D. K., Lehoux, P. N., Harnish, J. L., Shaul, R. Z., Bernstein, M., 
et  al. (2007). Adoption of an innovation to repair aortic aneurysms at a Canadian hospital: 
A qualitative case study and evaluation. BMC Health Services Research, 7, 10. https ://doi.
org/10.1186/1472-6963-7-182.
 16. De Ville, K. (2010). Bariatric surgery, ethical obligation, and the life cycle of medical innovation. 
American Journal of Bioethics, 10(12), 22–24. https ://doi.org/10.1080/15265 161.2010.52852 6.
 17. Department of Health, & Department of Business Energy and Industrial Strategy. (2017). Mak-
ing a reality of the accelerated access review. London: U.K. Government.
 18. Dixon-Woods, M., Cavers, D., Agarwal, S., Annandale, E., Arthur, A., Harvey, J., et al. (2006). 
Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable 
groups. BMC Medical Research Methodology, 6, 35. https ://doi.org/10.1186/1471-2288-6-35.
 19. Dunsmoor, J. E., & Murphy, G. L. (2014). Stimulus typicality determines how broadly fear is 
generalized. Psychological Science, 25(9), 1816–1821. https ://doi.org/10.1177/09567 97614 
53540 1.
 20. Filson, C. P., Banerjee, M., Wolf, J. S., Ye, Z. J., Wei, J. T., & Miller, D. C. (2011). Surgeon 
characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy. Jour-
nal of Urology, 185(6), 2072–2077. https ://doi.org/10.1016/j.juro.2011.02.057.
 21. Gani, F., Ford, D. E., & Pawlik, T. M. (2016). Potential barriers to the diffusion of surgical inno-
vation. Jama Surgery, 151(5), 403–404. https ://doi.org/10.1001/jamas urg.2016.0030.
 22. Gawande, A. (2012). Two hundred years of surgery. New England Journal of Medicine, 366(18), 
1716–1723. https ://doi.org/10.1056/NEJMr a1202 392.
 23. Geiger, J. D., & Hirschl, R. B. (2015). Innovation in surgical technology and techniques: 
Challenges and ethical issues. Seminars in Pediatric Surgery, 24(3), 115–121. https ://doi.
org/10.1053/j.sempe dsurg .2015.02.008.
 24. Healey, P., & Samanta, J. (2008). When does the ‘learning curve’ of innovative interventions 
become questionable practice? European Journal of Vascular and Endovascular Surgery, 36(3), 
253–257. https ://doi.org/10.1016/j.ejvs.2008.05.006.
1 3
Health Care Analysis 
 25. Hirst, A., Agha, R. A., Rosin, D., & McCulloch, P. (2013). How can we improve surgical 
research and innovation?: The IDEAL framework for action. International Journal of Surgery, 
11(10), 1038–1042. https ://doi.org/10.1016/j.ijsu.2013.09.016.
 26. Hirst, A., Philippou, Y., Blazeby, J., Campbell, B., Campbell, M., Feinberg, J., et  al. (2019). 
No surgical innovation without evaluation: Evolution and further development of the IDEAL 
framework and recommendations. Annals of Surgery, 269(2), 211–220. https ://doi.org/10.1097/
SLA.00000 00000 00279 4.
 27. Hokenstad, E. D., El-Nashar, S. A., Blandon, R. E., Occhino, J. A., Trabuco, E. C., Gebhart, J. 
B., et al. (2015). Health-related quality of life and outcomes after surgical treatment of compli-
cations from vaginally placed mesh. Female Pelvic Medicine & Reconstructive Surgery, 21(3), 
176–180. https ://doi.org/10.1097/SPV.00000 00000 00014 2.
 28. Hospers, G.-J. (2005). Joseph schumpeter and his legacy in innovation studies. Knowledge, Tech-
nology & Policy, 18(3), 20–37. https ://doi.org/10.1007/s1213 0-005-1003-1.
 29. Hughes-Hallett, A., Mayer, E. K., Marcus, H. J., Cundy, T. P., Pratt, P. J., Parston, G., et  al. 
(2014). Quantifying innovation in surgery. Annals of Surgery, 260(2), 205–211. https ://doi.
org/10.1097/sla.00000 00000 00066 2.
 30. Hutchison, K., Rogers, W., Eyers, A., & Lotz, M. (2015). Getting clearer about surgical innova-
tion: A new definition and a new tool to support responsible practice. Annals of Surgery, 262(6), 
949–954. https ://doi.org/10.1097/sla.00000 00000 00117 4.
 31. IDEAL Collaboration. (2017). The IDEAL collaboration. http://www.ideal -colla borat ion.net/. 
Accessed July 17, 2017.
 32. Jackson, F. (2000). From metaphysics to ethics: A defence of conceptual analysis. Oxford: Claren-
don Press.
 33. Johnson, J., & Rogers, W. (2012). Innovative surgery: The ethical challenges. Journal of Medical 
Ethics, 38(1), 9–12.
 34. Johnson, J., & Rogers, W. (2014). Joint issues–conflicts of interest, the ASR hip and sug-
gestions for managing surgical conflicts of interest. BMC Medical Ethics, 15, 63. https ://doi.
org/10.1186/1472-6939-15-63.
 35. Jones, J. W., McCullough, L. B., & Richman, B. W. (2004). Ethics of surgical innovation to treat rare 
diseases. Journal of Vascular Surgery, 39(4), 918–919. https ://doi.org/10.1016/j.jvs.2004.01.003.
 36. Karpowicz, L., Bell, E., & Racine, E. (2016). Ethics oversight mechanisms for surgical innova-
tion: A systematic and comparative review of arguments. Journal of Empirical Research on Human 
Research Ethics, 11(2), 135–164. https ://doi.org/10.1177/15562 64616 65011 7.
 37. Kelley, W. E., Jr. (2008). The evolution of laparoscopy and the revolution in surgery in the decade of 
the 1990s. JSLS: Journal of the Society of Laparoendoscopic Surgeons, 12(4), 351–357.
 38. Laakmann, A. B. (2015). When should physicians be liable for innovation. Cardozo Law Review, 
36(3), 913–968.
 39. Lee, C. B. (2016). Surgical innovation and safety: Femoroacetabular impingement and the IDEAL 
collaborative framework. Journal of Hip Preservation Surgery, 3(2), 89–96. https ://doi.org/10.1093/
jhps/hnv07 4.
 40. Lotz, M. (2013). Surgical innovation as sui generis surgical research. Theoretical Medicine and Bio-
ethics, 34(6), 447–459. https ://doi.org/10.1007/s1101 7-013-9272-2.
 41. Machery, E. (2009). Doing without concepts. Oxford: Oxford University Press.
 42. Margo, C. E. (2001). When is surgery research? Towards an operational definition of human 
research. Journal of Medical Ethics, 27(1), 40–43. https ://doi.org/10.1136/jme.27.1.40.
 43. Margolis, E., & Laurence, S. (2014). Concepts. Retrieved July 18, 2019, from https ://plato .stanf ord.
edu/archi ves/spr20 14/entri es/conce pts/.
 44. Mastroianni, A. C. (2006). Liability, regulation and policy in surgical innovation: The cutting edge 
of research and therapy. Health Matrix, 16(2), 351–442.
 45. Mavroudis, C., Mavroudis, C. D., Jacobs, M. L., & Jacobs, J. R. (2009). Ethics of innovation in sur-
gery for congenital cardiac diseases. Cardiology in the Young, 19, 100–105. https ://doi.org/10.1017/
s1047 95110 99916 97.
 46. McCulloch, P. (2009). Developing appropriate methodology for the study of surgical techniques. 
Journal of the Royal Society of Medicine, 102(2), 51–55. https ://doi.org/10.1258/jrsm.2008.08030 8.
 47. McCulloch, P., Kaul, A., Wagstaff, G. F., & Wheatcroft, J. (2005). Tolerance of uncertainty, extro-
version, neuroticism and attitudes to randomized controlled trials among surgeons and physicians. 
British Journal of Surgery, 92(10), 1293–1297. https ://doi.org/10.1002/bjs.4930.
 Health Care Analysis
1 3
 48. McCulloch, P., Altman, D. G., Campbell, W. B., Flum, D. R., Glasziou, P., Marshall, J. C., et al. 
(2009). Surgical innovation and evaluation 3 no surgical innovation without evaluation: The IDEAL 
recommendations. Lancet, 374(9695), 1105–1112.
 49. McKinlay, J. B. (1981). From promising report to standard procedure—7 stages in the career of a 
medical innovation. Milbank Memorial Fund Quarterly-Health and Society, 59(3), 374–411. https ://
doi.org/10.2307/33496 85.
 50. McKneally, M. F. (2011). The ethics of innovation: Columbus and others try something new. 
Journal of Thoracic and Cardiovascular Surgery, 141(4), 863–866. https ://doi.org/10.1016/j.jtcvs 
.2011.01.003.
 51. Menikoff, J. (2007). Beyond abigail alliance: The reality behind the right to get experimental drugs. 
Kansas Law Review, 56(5), 1045–1074.
 52. Meyerson, D. (2013). Innovative surgery and the precautionary principle. Journal of Medicine and 
Philosophy, 38(6), 605–624. https ://doi.org/10.1093/jmp/jht04 7.
 53. Meyerson, D. (2015). Is there a right to access innovative surgery? Bioethics, 29(5), 342–352.
 54. Miller, M. E., Siegler, M., & Angelos, P. (2014). Ethical issues in surgical innovation. World Jour-
nal of Surgery, 38(7), 1638–1643. https ://doi.org/10.1007/s0026 8-014-2568-1.
 55. Moojen, W. A., Bredenoord, A. L., Viergever, R. F., & Peul, W. C. (2014). Scientific evaluation of 
spinal implants: An ethical necessity. Spine, 39(26), 2115–2118. https ://doi.org/10.1097/brs.00000 
00000 00067 1.
 56. Morreim, H., Mack, M. J., & Sade, R. M. (2006). Surgical innovation: Too risky to remain 
unregulated? Annals of Thoracic Surgery, 82(6), 1957–1965. https ://doi.org/10.1016/j.athor acsur 
.2006.07.003.
 57. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 
(1978). Belmont report: Ethical principles and guidelines for the protection of human subjects of 
research. Washington, DC: Report of the National Commission for the Protection of Human Sub-
jects of Biomedical and Behavioral Research.
 58. Nemet, G. F. (2009). Demand-pull, technology-push, and government-led incentives for non-
incremental technical change. Research Policy, 38(5), 700–709. https ://doi.org/10.1016/j.respo 
l.2009.01.004.
 59. Neugebauer, E. A., Becker, M., Buess, G. F., Cuschieri, A., Dauben, H. P., Fingerhut, A., et  al. 
(2010). EAES recommendations on methodology of innovation management in endoscopic surgery. 
Surgical Endoscopy, 24(7), 1594–1615. https ://doi.org/10.1007/s0046 4-009-0818-3.
 60. Nobel Foundation. (2018). Werner Forssmann—Biographical. https ://www.nobel prize .org/nobel 
_prize s/medic ine/laure ates/1956/forss mann-bio.html. January 9, 2018.
 61. Nwomeh, B. C., & Caniano, D. A. (2011). Emerging ethical issues in pediatric surgery. Pediatric 
Surgery International, 27(6), 555–562. https ://doi.org/10.1007/s0038 3-011-2907-3.
 62. Paul, S., McCulloch, P., & Sedrakyan, A. (2013). Robotic surgery: Revisiting “no innovation with-
out evaluation”: National registries must be created so that this technology can be properly evalu-
ated. BMJ: British Medical Journal, 346(7901), 8–8. https ://doi.org/10.1136/bmj.f1573 .
 63. Piccinini, G., & Scott, S. (2006). Splitting concepts. Philosophy of Science, 73(4), 390–409. https ://
doi.org/10.1086/51680 6.
 64. Reitsma, A. M., & Moreno, J. D. (2002). Ethical regulations for innovative surgery: The last fron-
tier? Journal of the American College of Surgeons, 194(6), 792–801. https ://doi.org/10.1016/s1072 
-7515(02)01153 -5.
 65. Reitsma, A. M., & Moreno, J. D. (2003). Surgical research, an elusive entity. American Journal of 
Bioethics, 3(4), 49–50. https ://doi.org/10.1162/15265 16033 22614 599.
 66. Reitsma, A. M., & Moreno, J. D. (2005). Ethics of innovative surgery: US surgeons’ definitions, 
knowledge, and attitudes. Journal of the American College of Surgeons, 200(1), 103–110. https ://
doi.org/10.1016/j.jamco llsur g.2004.09.032.
 67. Riskin, D. J., Longaker, M. T., Gertner, M., & Krummel, T. M. (2006). Innovation in surgery—
A historical perspective. Annals of Surgery, 244(5), 686–693. https ://doi.org/10.1097/01.sla.00002 
42706 .91771 .ce.
 68. Rogers, E. (2003). Diffusion of innovation (5th ed.). London: Free Press.
 69. Rogers, W. A., & Johnson, J. (2013). Addressing within-role conflicts of interest in surgery. Journal 
of Bioethical Inquiry, 10(2), 219–225. https ://doi.org/10.1007/s1167 3-013-9431-1.
 70. Rogers, W. A., Lotz, M., Hutchison, K., Pourmoslemi, A., & Eyers, A. (2014). Identifying surgical 
innovation a qualitative study of surgeons’ views. Annals of Surgery, 259(2), 273–278. https ://doi.
org/10.1097/SLA.0b013 e3182 9ccc5 f.
1 3
Health Care Analysis 
 71. Rogers, W., & Blakeley, B. (2018). Identifying surgical innovation in real time: A pilot study. In 
Paper presented at the IDEAL conference, Bristol, UK, 13th September.
 72. Schumpeter, J. A. (1949). The theory of economic development (R. Opie, Trans.). Cambridge: Har-
vard University Press.
 73. Schwartz, J. A. T. (2014). Innovation in pediatric surgery: The surgical innovation continuum and 
the ETHICAL model. Journal of Pediatric Surgery, 49(4), 639–645. https ://doi.org/10.1016/j.jpeds 
urg.2013.12.016.
 74. Sinnott-Armstrong, W. (2000). A perspectival theory of law. In T. Campbell & J. Goldsworthy 
(Eds.), Judicial power, democracy and legal positivism (pp. 185–213). Dartmouth: Ashgate.
 75. Sood, A., McCulloch, P., Dahm, P., Ahlawat, R., Jeong, W. J., Bhandari, M., et al. (2016). Ontog-
eny of a surgical technique: Robotic kidney transplantation with regional hypothermia. International 
Journal of Surgery, 25, 158–161. https ://doi.org/10.1016/j.ijsu.2015.12.061.
 76. Stefanidis, D., Fanelli, R. D., Price, R., Richardson, W., & Comm, S. G. (2014). SAGES guidelines 
for the introduction of new technology and techniques. Surgical Endoscopy and Other Interven-
tional Techniques, 28(8), 2257–2271. https ://doi.org/10.1007/s0046 4-014-3587-6.
 77. Stephenson, G. (2003). The somewhat flawed theoretical foundation of the extension service. Jour-
nal of Extension, 41(4), 4FEA1.
 78. West, J. B. (2017). The beginnings of cardiac catheterization and the resulting impact on pulmo-
nary medicine. American Journal of Physiology. Lung Cellular and Molecular Physiology, 313(4), 
L651–L658. https ://doi.org/10.1152/ajplu ng.00133 .2017.
 79. Wilson, C. B. (2006). Surgery—Adoption of new surgical technology. British Medical Journal, 
332(7533), 112–114. https ://doi.org/10.1136/bmj.332.7533.112.
 80. Wittgenstein, L. (1958). Philosophical investigations (G. E. M. Anscombe, Trans., 3rd edn.). 
Oxford: Blackwell.
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published 
maps and institutional affiliations.
